Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Calabrò

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Minerva Endocrinologica|July 1, 1991
Primary hyperparathyroidism. Our experienceL De Marinis, A Mancini, R Sciuto, et al.
Minerva Medica|April 1, 1990
[The role of autoimmune mechanisms in the hyperthyroidism-viral hepatitis syndrome: a possible noncausal association. A review of the literature and the authors' own cases]A Mancini, L De Marinis, C Fiumara, et al.
Minerva Chirurgica|June 15, 1981
[Typical, atypical and malignant bronchial carcinoid]F Sartori, R Binda, F Calabrò, et al.
Minerva Chirurgica|June 15, 1981
[Bronchial cylindroma (adenocystic carcinoma)]F Sartori, R Binda, F Calabrò, et al.
European Urology|April 18, 2001
Differences in gene expression in muscle-invasive bladder cancer: a comparison of Italian and American patientsS G Williams, R Gandour-Edwards, A D Deitch, et al.
ESMO Open|May 13, 2021
SAUL, a single-arm study of atezolizumab for chemotherapy-pretreated locally advanced or metastatic carcinoma of the urinary tract: outcomes by key baseline factors, PD-L1 expression and prior platinum therapyA Bamias, A S Merseburger, Y Loriot, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysisA Santo, R Pedersini, F Pasini, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinomaL Antonuzzo, M Maruzzo, U De Giorgi, et al.
ESMO Open|May 13, 2021
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohortG Fornarini, S E Rebuzzi, G L Banna, et al.
ESMO Open|December 9, 2022
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access ProgramS E Rebuzzi, A Signori, S Buti, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Minerva Endocrinologica|July 1, 1991
Primary hyperparathyroidism. Our experienceL De Marinis, A Mancini, R Sciuto, et al.
Minerva Medica|April 1, 1990
[The role of autoimmune mechanisms in the hyperthyroidism-viral hepatitis syndrome: a possible noncausal association. A review of the literature and the authors' own cases]A Mancini, L De Marinis, C Fiumara, et al.
Minerva Chirurgica|June 15, 1981
[Typical, atypical and malignant bronchial carcinoid]F Sartori, R Binda, F Calabrò, et al.
Minerva Chirurgica|June 15, 1981
[Bronchial cylindroma (adenocystic carcinoma)]F Sartori, R Binda, F Calabrò, et al.
European Urology|April 18, 2001
Differences in gene expression in muscle-invasive bladder cancer: a comparison of Italian and American patientsS G Williams, R Gandour-Edwards, A D Deitch, et al.
ESMO Open|May 13, 2021
SAUL, a single-arm study of atezolizumab for chemotherapy-pretreated locally advanced or metastatic carcinoma of the urinary tract: outcomes by key baseline factors, PD-L1 expression and prior platinum therapyA Bamias, A S Merseburger, Y Loriot, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysisA Santo, R Pedersini, F Pasini, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinomaL Antonuzzo, M Maruzzo, U De Giorgi, et al.
ESMO Open|May 13, 2021
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohortG Fornarini, S E Rebuzzi, G L Banna, et al.
ESMO Open|December 9, 2022
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access ProgramS E Rebuzzi, A Signori, S Buti, et al.
Pageof 9